Laura O Hern, PA
Physician Assistant · Little Rock, ARNPI 1346556511
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 335 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 9.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,989, 2.3 times the $874 reported in 2021. Among physician assistant clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 335 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$641
- Sanofi-aventis U.S. LLC$612
- Amgen$506
- Bayer$504
- Insulet Corporation$445
- Abbott$427
- plus $4K from 28 others
What the payments were for
- Speaking & faculty fees$1252%
- Food & beverage$6,74998%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 39 | $641 |
| Sanofi-aventis U.S. LLC | 31 | $612 |
| Amgen(2 entities) | 35 | $506 |
| Bayer | 27 | $504 |
| Insulet Corporation | 15 | $445 |
| Abbott | 17 | $427 |
| Dexcom, Inc. | 43 | $389 |
| Cequr Corporation | 2 | $379 |
| Novo Nordisk | 12 | $373 |
| AbbVie | 14 | $326 |
| Corcept Therapeutics | 17 | $308 |
| Tandem Diabetes Care, Inc. | 7 | $264 |
| Esperion Therapeutics, Inc. | 10 | $249 |
| Xeris Pharmaceuticals, Inc. | 12 | $232 |
| BETA Bionics, Inc. | 6 | $167 |
| Sequel Med Tech, LLC | 3 | $148 |
| Boehringer Ingelheim | 9 | $147 |
| Novartis | 8 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $125 |
| Ascendis Pharma Endocrinology Inc | 5 | $87 |
| Radius Health, Inc. | 3 | $55 |
| Averitas Pharma Inc. | 2 | $54 |
| Nevro Corp. | 3 | $43 |
| Antares Pharma, Inc. | 2 | $40 |
| Rhythm Pharmaceuticals, Inc. | 2 | $39 |
| Recordati_rare_diseases_inc. | 2 | $38 |
| Kyowa Kirin, Inc. | 1 | $27 |
| Merck | 1 | $23 |
| Ascensia Diabetes Care US Inc. | 1 | $22 |
| Mannkind Corporation | 1 | $20 |
| Halozyme Inc | 1 | $20 |
| Soleno Therapeutics, Inc. | 1 | $19 |
| Chiesi USA, Inc. | 1 | $15 |
| AstraZeneca | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CeQur Simplicity$379
- Ozempic$228
- NATPARA (PARATHYROID HORMONE)$125
- TWIIST$111
- NEXLIZET$106
- NEXLETOL$106
- Omnipod$105
How this compares
$6,894 in reported general payments places this provider in the 90th percentile of 451 physician assistant providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 331 | $344,845 |
| OzempicSemaglutide | 245 | $266,570 |
| Tresiba Flextouch U-200Insulin Degludec | 114 | $121,696 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 51 | $77,568 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 62 | $44,612 |
| Tresiba Flextouch U-100Insulin Degludec | 56 | $35,404 |
| JardianceEmpagliflozin | 30 | $34,847 |
| FarxigaDapagliflozin Propanediol | 38 | $26,351 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 26 | $23,882 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 17 | $20,963 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 42 | $19,135 |
| Xigduo XrDapaglifloz Propaned/Metformin | 18 | $17,304 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $16,909 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 16 | $15,784 |
| NovologInsulin Aspart | 55 | $14,245 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Humalog, Insulin Lispro | $641 | $350,699359 claims |
| Novo NordiskOzempic, Novolog, Fiasp | $373 | $290,688313 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $147 | $43,55545 claims |
| AstraZenecaFarxiga | $15 | $26,35138 claims |
| Sanofi-aventis U.S. LLCAdmelog | $612 | $13,64720 claims |
| AbbVieSynthroid | $326 | $3,34357 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 451 physician assistant providers in Arkansas.
Other physician assistant in Little Rock
- Katherine RossLittle Rock$44K
- Timothy BookerLittle Rock$13K
- Katlyn McClureLittle Rock$9K
- Aaron ParsleyLittle Rock$9K
- Payton WilliamsLittle Rock$8K
- Chelsea NeweyLittle Rock$8K
- Gregory BellLittle Rock$8K
- Alissa HubertyLittle Rock$8K
- Hailey ArensLittle Rock$8K
- Elizabeth TurbevilleLittle Rock$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.